Search

everythinglearnresearchcommunity

for

Search:↓

Younger women are seen as more attractive and healthier, with Chinese women rated highest and South African women rated oldest and least healthy.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Most women lack knowledge about androgens and their excess symptoms.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Women with PCOS may have a higher risk of Alzheimer's disease.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Ashwagandha is safe and effective for reducing perimenopausal symptoms.

Hirsutism in Afghan women varies by community, influenced by awareness, education, and socio-economic status.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Women with PCOS may be more likely to have gum disease than healthy women.

Women with hair loss may benefit from higher iron levels.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.